{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:14:30Z","timestamp":1793830470107,"version":"4.6.1"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T00:00:00Z","timestamp":1521676800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,3,22]],"date-time":"2018-03-22T00:00:00Z","timestamp":1521676800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Death Dis"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Microglia-mediated neuroinflammation is implicated in multiple neurodegenerative disorders, including Parkinson\u2019s disease (PD). Hence, the modulatioein of sustained microglial activation may have therapeutic potential. This study is designed to test the neuroprotective efficacy of taurine, a major intracellular free \u03b2-amino acid in mammalian tissues, by using paraquat and maneb-induced PD model. Results showed that mice intoxicated with paraquat and maneb displayed progressive dopaminergic neurodegeneration and motor deficits, which was significantly ameliorated by taurine. Taurine also attenuated the aggregation of \u03b1-synuclein in paraquat and maneb-intoxicated mice. Mechanistically, taurine suppressed paraquat and maneb-induced microglial activation. Moreover, depletion of microglia abrogated the dopaminergic neuroprotective effects of taurine, revealing the role of microglial activation in taurine-afforded neuroprotection. Subsequently, we found that taurine suppressed paraquat and maneb-induced microglial M1 polarization and gene expression levels of proinflammatory factors. Furthermore, taurine was shown to be able to inhibit the activation of NADPH oxidase (NOX2) by interfering with membrane translocation of cytosolic subunit, p47<jats:sup>phox<\/jats:sup> and nuclear factor-kappa B (NF-\u03baB) pathway, two key factors for the initiation and maintenance of M1 microglial inflammatory response. Altogether, our results showed that taurine exerted dopaminergic neuroprotection through inactivation of microglia-mediated neuroinflammation, providing a promising avenue and candidate for the potential therapy for patients suffering from PD.<\/jats:p>","DOI":"10.1038\/s41419-018-0468-2","type":"journal-article","created":{"date-parts":[[2018,4,4]],"date-time":"2018-04-04T02:29:06Z","timestamp":1522808946000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":151,"title":["Taurine protects dopaminergic neurons in a mouse Parkinson\u2019s disease model through inhibition of microglial M1 polarization"],"prefix":"10.1038","volume":"9","author":[{"given":"Yuning","family":"Che","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liyan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuqiang","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaofang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengyuan","family":"Piao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,3,22]]},"reference":[{"key":"468_CR1","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1146\/annurev.neuro.22.1.123","volume":"22","author":"CW Olanow","year":"1999","unstructured":"Olanow, C. W. & Tatton, W. G. Etiology and pathogenesis of Parkinson\u2019s disease. Annu. Rev. Neurosci. 22, 123\u2013144 (1999).","journal-title":"Annu. Rev. Neurosci."},{"key":"468_CR2","doi-asserted-by":"publisher","first-page":"55","DOI":"10.4103\/1596-3519.64743","volume":"9","author":"F Salawu","year":"2010","unstructured":"Salawu, F., Olokoba, A. & Danburam, A. Current management of Parkinson\u2019s disease. Ann. Afr. Med. 9, 55\u201361 (2010).","journal-title":"Ann. Afr. Med."},{"key":"468_CR3","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1016\/j.tins.2013.06.003","volume":"36","author":"L Brichta","year":"2013","unstructured":"Brichta, L., Greengard, P. & Flajolet, M. Advances in the pharmacological treatment of Parkinson\u2019s disease: targeting neurotransmitter systems. Trends Neurosci. 36, 543\u2013554 (2013).","journal-title":"Trends Neurosci."},{"key":"468_CR4","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1002\/mds.22432","volume":"24","author":"RG Hart","year":"2009","unstructured":"Hart, R. G., Pearce, L. A., Ravina, B. M., Yaltho, T. C. & Marler, J. R. Neuroprotection trials in Parkinson\u2019s disease: systematic review. Mov. Disord. 24, 647\u2013654 (2009).","journal-title":"Mov. Disord."},{"key":"468_CR5","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrn2038","volume":"8","author":"ML Block","year":"2007","unstructured":"Block, M. L., Zecca, L. & Hong, J. S. Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat. Rev. Neurosci. 8, 57\u201369 (2007).","journal-title":"Nat. Rev. Neurosci."},{"key":"468_CR6","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.it.2008.05.002","volume":"29","author":"HM Gao","year":"2008","unstructured":"Gao, H. M. & Hong, J. S. Why neurodegenerative diseases are progressive: uncontrolled inflammation drives disease progression. Trends Immunol. 29, 357\u2013365 (2008).","journal-title":"Trends Immunol."},{"key":"468_CR7","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1016\/S1474-4422(09)70062-6","volume":"8","author":"EC Hirsch","year":"2009","unstructured":"Hirsch, E. C. & Hunot, S. Neuroinflammation in Parkinson\u2019s disease: a target for neuroprotection? Lancet Neurol. 8, 382\u2013397 (2009).","journal-title":"Lancet Neurol."},{"key":"468_CR8","doi-asserted-by":"publisher","first-page":"6309","DOI":"10.1523\/JNEUROSCI.20-16-06309.2000","volume":"20","author":"WG Kim","year":"2000","unstructured":"Kim, W. G. et al. Regional difference in susceptibility to lipopolysaccharide-induced neurotoxicity in the rat brain: role of microglia. J. Neurosci. 20, 6309\u20136316 (2000).","journal-title":"J. Neurosci."},{"key":"468_CR9","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1042\/CS20150008","volume":"129","author":"Q Wang","year":"2015","unstructured":"Wang, Q., Oyarzabal, E., Wilson, B., Qian, L. & Hong, J. S. Substance P enhances microglial density in the substantia nigra through neurokinin-1 receptor\/NADPH oxidase-mediated chemotaxis in mice. Clin. Sci. (Lond.). 129, 757\u2013767 (2015).","journal-title":"Clin. Sci. (Lond.)."},{"key":"468_CR10","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1289\/ehp.6361","volume":"111","author":"B Liu","year":"2003","unstructured":"Liu, B., Gao, H. M. & Hong, J. S. Parkinson\u2019s disease and exposure to infectious agents and pesticides and the occurrence of brain injuries: role of neuroinflammation. Environ. Health Perspect. 111, 1065\u20131073 (2003).","journal-title":"Environ. Health Perspect."},{"key":"468_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.3389\/fnana.2014.00155","volume":"8","author":"J Blesa","year":"2014","unstructured":"Blesa, J. & Przedborski, S. Parkinson\u2019s disease: animal models and dopaminergic cell vulnerability. Front. Neuroanat. 8, 155 (2014).","journal-title":"Front. Neuroanat."},{"key":"468_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3389\/fnana.2014.00152","volume":"8","author":"L Brichta","year":"2014","unstructured":"Brichta, L. & Greengard, P. Molecular determinants of selective dopaminergic vulnerability in Parkinson\u2019s disease: an update. Front. Neuroanat. 8, 152 (2014).","journal-title":"Front. Neuroanat."},{"key":"468_CR13","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/nrn.2016.178","volume":"18","author":"DJ Surmeier","year":"2017","unstructured":"Surmeier, D. J., Obeso, J. A. & Halliday, G. M. Selective neuronal vulnerability in Parkinson disease. Nat. Rev. Neurosci. 18, 101\u2013113 (2017).","journal-title":"Nat. Rev. Neurosci."},{"key":"468_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s00726-012-1382-z","volume":"46","author":"J Menzie","year":"2014","unstructured":"Menzie, J., Pan, C., Prentice, H. & Wu, J. Y. Taurine and central nervous system disorders. Amino. Acids 46, 31\u201346 (2014).","journal-title":"Amino. Acids"},{"key":"468_CR15","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1007\/s00726-012-1361-4","volume":"46","author":"J Marcinkiewicz","year":"2014","unstructured":"Marcinkiewicz, J. & Kontny, E. Taurine and inflammatory diseases. Amino. Acids 46, 7\u201320 (2014).","journal-title":"Amino. Acids"},{"key":"468_CR16","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1016\/0304-3940(96)12821-4","volume":"212","author":"M Ruotsalainen","year":"1996","unstructured":"Ruotsalainen, M. & Ahtee, L. Intrastriatal taurine increases striatal extracellular dopamine in a tetrodotoxin-sensitive manner in rats. Neurosci. Lett. 212, 175\u2013178 (1996).","journal-title":"Neurosci. Lett."},{"key":"468_CR17","first-page":"630","volume":"126","author":"L Zhang","year":"2016","unstructured":"Zhang, L. et al. Reduced plasma taurine level in Parkinson\u2019s disease: association with motor severity and levodopa treatment. Int. J. Neurosci. 126, 630\u2013636 (2016).","journal-title":"Int. J. Neurosci."},{"key":"468_CR18","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1016\/j.ejphar.2016.03.006","volume":"777","author":"Z Han","year":"2016","unstructured":"Han, Z. et al. Neuroprotection of taurine against reactive oxygen species is associated with inhibiting NADPH oxidases. Eur. J. Pharmacol. 777, 129\u2013135 (2016).","journal-title":"Eur. J. Pharmacol."},{"key":"468_CR19","doi-asserted-by":"publisher","first-page":"295","DOI":"10.1016\/j.brainresbull.2016.06.010","volume":"124","author":"XY Zhu","year":"2016","unstructured":"Zhu, X. Y. et al. Neuroprotective actions of taurine on hypoxic-ischemic brain damage in neonatal rats. Brain. Res. Bull. 124, 295\u2013305 (2016).","journal-title":"Brain. Res. Bull."},{"key":"468_CR20","doi-asserted-by":"publisher","first-page":"408","DOI":"10.3389\/fnins.2016.00408","volume":"10","author":"M Ingelsson","year":"2016","unstructured":"Ingelsson, M. Alpha-synuclein oligomers-neurotoxic molecules in Parkinson\u2019s disease and other Lewy body disorders. Front. Neurosci. 10, 408 (2016).","journal-title":"Front. Neurosci."},{"key":"468_CR21","doi-asserted-by":"publisher","DOI":"10.1038\/srep24526","volume":"6","author":"L Pieri","year":"2016","unstructured":"Pieri, L., Madiona, K. & Melki, R. Structural and functional properties of prefibrillar alpha-synuclein oligomers. Sci. Rep. 6, 24526 (2016).","journal-title":"Sci. Rep."},{"key":"468_CR22","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.neubiorev.2016.07.010","volume":"68","author":"AA Moustafa","year":"2016","unstructured":"Moustafa, A. A. et al. Motor symptoms in Parkinson\u2019s disease: a unified framework. Neurosci. Biobehav. Rev. 68, 727\u2013740 (2016).","journal-title":"Neurosci. Biobehav. Rev."},{"key":"468_CR23","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/978-94-024-1079-2_16","volume":"975","author":"S Li","year":"2017","unstructured":"Li, S. et al. Taurine ameliorates arsenic-induced apoptosis in the hippocampus of mice through intrinsic pathway. Adv. Exp. Med. Biol. 975, 183\u2013192 (2017).","journal-title":"Adv. Exp. Med. Biol."},{"key":"468_CR24","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1002\/glia.22738","volume":"63","author":"SH Chen","year":"2015","unstructured":"Chen, S. H. et al. Microglial regulation of immunological and neuroprotective functions of astroglia. Glia 63, 118\u2013131 (2015).","journal-title":"Glia"},{"key":"468_CR25","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/bph.13139","volume":"173","author":"R Orihuela","year":"2016","unstructured":"Orihuela, R., McPherson, C. A. & Harry, G. J. Microglial M1\/M2 polarization and metabolic states. Br. J. Pharmacol. 173, 649\u2013665 (2016).","journal-title":"Br. J. Pharmacol."},{"key":"468_CR26","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/j.1471-4159.2011.07572.x","volume":"120","author":"SH Choi","year":"2012","unstructured":"Choi, S. H., Aid, S., Kim, H. W., Jackson, S. H. & Bosetti, F. Inhibition of NADPH oxidase promotes alternative and anti-inflammatory microglial activation during neuroinflammation. J. Neurochem. 120, 292\u2013301 (2012).","journal-title":"J. Neurochem."},{"key":"468_CR27","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1016\/S0163-7827(03)00014-6","volume":"42","author":"K Uchida","year":"2003","unstructured":"Uchida, K. 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog. Lipid Res. 42, 318\u2013343 (2003).","journal-title":"Prog. Lipid Res."},{"key":"468_CR28","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/S0079-6123(10)84002-6","volume":"184","author":"JR Cannon","year":"2010","unstructured":"Cannon, J. R. & Greenamyre, J. T. Neurotoxic in vivo models of Parkinson\u2019s disease recent advances. Prog. Brain. Res. 184, 17\u201333 (2010).","journal-title":"Prog. Brain. Res."},{"key":"468_CR29","doi-asserted-by":"publisher","first-page":"1247","DOI":"10.1093\/brain\/awv034","volume":"138","author":"Q Wang","year":"2015","unstructured":"Wang, Q. et al. Post-treatment with an ultra-low dose of NADPH oxidase inhibitor diphenyleneiodonium attenuates disease progression in multiple Parkinson\u2019s disease models. Brain 138, 1247\u20131262 (2015).","journal-title":"Brain"},{"key":"468_CR30","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1016\/j.brainres.2015.06.041","volume":"1622","author":"FK Alkholifi","year":"2015","unstructured":"Alkholifi, F. K. & Albers, D. S. Attenuation of rotenone toxicity in SY5Y cells by taurine and N-acetyl cysteine alone or in combination. Brain. Res. 1622, 409\u2013413 (2015).","journal-title":"Brain. Res."},{"key":"468_CR31","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.neulet.2007.09.068","volume":"429","author":"I Santa-Maria","year":"2007","unstructured":"Santa-Maria, I., Hernandez, F., Moreno, F. J. & Avila, J. Taurine, an inducer for tau polymerization and a weak inhibitor for amyloid-beta-peptide aggregation. Neurosci. Lett. 429, 91\u201394 (2007).","journal-title":"Neurosci. Lett."},{"key":"468_CR32","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/S0028-3908(02)00310-6","volume":"44","author":"N del Olmo","year":"2003","unstructured":"del Olmo, N. et al. Taurine-induced synaptic potentiation and the late phase of long-term potentiation are related mechanistically. Neuropharmacology 44, 26\u201339 (2003).","journal-title":"Neuropharmacology"},{"key":"468_CR33","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1007\/s10072-013-1444-3","volume":"34","author":"H Javed","year":"2013","unstructured":"Javed, H. et al. Taurine ameliorates neurobehavioral, neurochemical and immunohistochemical changes in sporadic dementia of Alzheimer\u2019s type (SDAT) caused by intracerebroventricular streptozotocin in rats. Neurol. Sci. 34, 2181\u20132192 (2013).","journal-title":"Neurol. Sci."},{"key":"468_CR34","volume":"9","author":"Q Wang","year":"2012","unstructured":"Wang, Q. et al. Endogenous dynorphin protects against neurotoxin-elicited nigrostriatal dopaminergic neuron damage and motor deficits in mice. J. Neuroinflamm. 9, 124 (2012).","journal-title":"J. Neuroinflamm."},{"key":"468_CR35","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1074\/jbc.M307657200","volume":"279","author":"L Qin","year":"2004","unstructured":"Qin, L. et al. NADPH oxidase mediates lipopolysaccharide-induced neurotoxicity and proinflammatory gene expression in activated microglia. J. Biol. Chem. 279, 1415\u20131421 (2004).","journal-title":"J. Biol. Chem."},{"key":"468_CR36","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1002\/glia.20467","volume":"55","author":"L Qin","year":"2007","unstructured":"Qin, L. et al. Systemic LPS causes chronic neuroinflammation and progressive neurodegeneration. Glia 55, 453\u2013462 (2007).","journal-title":"Glia"},{"key":"468_CR37","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/cdd.2013.159","volume":"21","author":"Y Tang","year":"2014","unstructured":"Tang, Y. et al. Jmjd3 is essential for the epigenetic modulation of microglia phenotypes in the immune pathogenesis of Parkinson\u2019s disease. Cell. Death. Differ. 21, 369\u2013380 (2014).","journal-title":"Cell. Death. Differ."},{"key":"468_CR38","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1159\/000111317","volume":"15","author":"T Palackal","year":"1993","unstructured":"Palackal, T., Neuringer, M. & Sturman, J. Laminar analysis of the number of neurons, astrocytes, oligodendrocytes and microglia in the visual cortex (area 17) of 6- and 12-month-old rhesus monkeys fed a human infant soy-protein formula with or without taurine supplementation from birth. Dev. Neurosci. 15, 54\u201367 (1993).","journal-title":"Dev. Neurosci."},{"key":"468_CR39","doi-asserted-by":"publisher","first-page":"233","DOI":"10.3389\/fnagi.2017.00233","volume":"9","author":"Z Liu","year":"2017","unstructured":"Liu, Z. et al. Curcumin protects against ischemic stroke by titrating microglia\/macrophage polarization. Front. Aging Neurosci. 9, 233 (2017).","journal-title":"Front. Aging Neurosci."},{"key":"468_CR40","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1016\/j.bbi.2016.05.020","volume":"58","author":"Y Tao","year":"2016","unstructured":"Tao, Y. et al. Cannabinoid receptor-2 stimulation suppresses neuroinflammation by regulating microglial M1\/M2 polarization through the cAMP\/PKA pathway in an experimental GMH rat model. Brain. Behav. Immun. 58, 118\u2013129 (2016).","journal-title":"Brain. Behav. Immun."},{"key":"468_CR41","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/nri1312","volume":"4","author":"JD Lambeth","year":"2004","unstructured":"Lambeth, J. D. NOX enzymes and the biology of reactive oxygen. Nat. Rev. Immunol. 4, 181\u2013189 (2004).","journal-title":"Nat. Rev. Immunol."},{"key":"468_CR42","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1002\/glia.22762","volume":"63","author":"T Taetzsch","year":"2015","unstructured":"Taetzsch, T. et al. Redox regulation of NF-kappaB p50 and M1 polarization in microglia. Glia 63, 423\u2013440 (2015).","journal-title":"Glia"},{"key":"468_CR43","doi-asserted-by":"publisher","first-page":"12490","DOI":"10.1523\/JNEUROSCI.2238-14.2014","volume":"34","author":"Q Wang","year":"2014","unstructured":"Wang, Q. et al. Substance P exacerbates dopaminergic neurodegeneration through neurokinin-1 receptor-independent activation of microglial NADPH oxidase. J. Neurosci. 34, 12490\u201312503 (2014).","journal-title":"J. Neurosci."},{"key":"468_CR44","doi-asserted-by":"publisher","first-page":"2034","DOI":"10.1002\/glia.22724","volume":"62","author":"Q Wang","year":"2014","unstructured":"Wang, Q. et al. Subpicomolar diphenyleneiodonium inhibits microglial NADPH oxidase with high specificity and shows great potential as a therapeutic agent for neurodegenerative diseases. Glia 62, 2034\u20132043 (2014).","journal-title":"Glia"},{"key":"468_CR45","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1016\/j.bbi.2016.07.158","volume":"58","author":"A Kumar","year":"2016","unstructured":"Kumar, A. et al. NOX2 drives M1-like microglial\/macrophage activation and neurodegeneration following experimental traumatic brain injury. Brain. Behav. Immun. 58, 291\u2013309 (2016).","journal-title":"Brain. Behav. Immun."},{"key":"468_CR46","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.freeradbiomed.2008.09.025","volume":"46","author":"Y Li","year":"2009","unstructured":"Li, Y., Arnold, J. M., Pampillo, M., Babwah, A. V. & Peng, T. Taurine prevents cardiomyocyte death by inhibiting NADPH oxidase-mediated calpain activation. Free. Radic. Biol. Med. 46, 51\u201361 (2009).","journal-title":"Free. Radic. Biol. Med."},{"key":"468_CR47","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1016\/j.fct.2014.05.023","volume":"71","author":"CA Agca","year":"2014","unstructured":"Agca, C. A., Tuzcu, M., Hayirli, A. & Sahin, K. Taurine ameliorates neuropathy via regulating NF-kappaB and Nrf2\/HO-1 signaling cascades in diabetic rats. Food Chem. Toxicol. 71, 116\u2013121 (2014).","journal-title":"Food Chem. Toxicol."},{"key":"468_CR48","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1007\/978-0-387-75681-3_48","volume":"643","author":"C Kim","year":"2009","unstructured":"Kim, C. & Cha, Y. N. Production of reactive oxygen and nitrogen species in phagocytes is regulated by taurine chloramine. Adv. Exp. Med. Biol. 643, 463\u2013472 (2009).","journal-title":"Adv. Exp. Med. Biol."},{"key":"468_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.tox.2017.02.009","volume":"380","author":"L Hou","year":"2017","unstructured":"Hou, L. et al. Paraquat and maneb co-exposure induces noradrenergic locus coeruleus neurodegeneration through NADPH oxidase-mediated microglial activation. Toxicology 380, 1\u201310 (2017).","journal-title":"Toxicology"},{"key":"468_CR50","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1096\/fj.03-0983fje","volume":"18","author":"W Zhang","year":"2004","unstructured":"Zhang, W. et al. Neuroprotective effect of dextromethorphan in the MPTP Parkinson\u2019s disease model: role of NADPH oxidase. Faseb. J. 18, 589\u2013591 (2004).","journal-title":"Faseb. J."},{"key":"468_CR51","doi-asserted-by":"publisher","first-page":"2983","DOI":"10.1007\/s12035-015-9179-1","volume":"53","author":"A Kumar","year":"2016","unstructured":"Kumar, A., Leinisch, F., Kadiiska, M. B., Corbett, J. & Mason, R. P. Formation and implications of alpha-synuclein radical in maneb- and paraquat-induced models of Parkinson\u2019s disease. Mol. Neurobiol. 53, 2983\u20132994 (2016).","journal-title":"Mol. Neurobiol."},{"key":"468_CR52","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.redox.2017.09.017","volume":"14","author":"L Hou","year":"2017","unstructured":"Hou, L. et al. Complement receptor 3 mediates NADPH oxidase activation and dopaminergic neurodegeneration through a Src-Erk-dependent pathway. Redox Biol. 14, 250\u2013260 (2017).","journal-title":"Redox Biol."},{"key":"468_CR53","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.redox.2017.02.016","volume":"12","author":"L Hou","year":"2017","unstructured":"Hou, L. et al. NADPH oxidase-derived H2O2 mediates the regulatory effects of microglia on astrogliosis in experimental models of Parkinson\u2019s disease. Redox Biol. 12, 162\u2013170 (2017).","journal-title":"Redox Biol."},{"key":"468_CR54","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/978-1-62703-520-0_21","volume":"1041","author":"SH Chen","year":"2013","unstructured":"Chen, S. H., Oyarzabal, E. A. & Hong, J. S. Preparation of rodent primary cultures for neuron-glia, mixed glia, enriched microglia, and reconstituted cultures with microglia. Methods Mol. Biol. 1041, 231\u2013240 (2013).","journal-title":"Methods Mol. Biol."},{"key":"468_CR55","doi-asserted-by":"publisher","DOI":"10.1186\/s12974-016-0573-z","volume":"13","author":"L Jiang","year":"2016","unstructured":"Jiang, L. et al. Clozapine metabolites protect dopaminergic neurons through inhibition of microglial NADPH oxidase. J. Neuroinflamm. 13, 110 (2016).","journal-title":"J. Neuroinflamm."}],"container-title":["Cell Death &amp; Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0468-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0468-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0468-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T11:52:16Z","timestamp":1671537136000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41419-018-0468-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3,22]]},"references-count":55,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2018,4]]}},"alternative-id":["468"],"URL":"https:\/\/doi.org\/10.1038\/s41419-018-0468-2","relation":{},"ISSN":["2041-4889"],"issn-type":[{"value":"2041-4889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3,22]]},"assertion":[{"value":"21 December 2017","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 February 2018","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2018","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 March 2018","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare that they have no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"435"}}